| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | G L Mutter | |
| P2860 | cites work | P-TEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase | Q24322705 |
| K-ras mutations appear in the premalignant phase of both microsatellite stable and unstable endometrial carcinogenesis | Q24568160 | ||
| hMLH1 promoter hypermethylation is an early event in human endometrial tumorigenesis | Q24670424 | ||
| Architectural and nuclear morphometrical features together are more important prognosticators in endometrial hyperplasias than nuclear morphometrical features alone | Q68416823 | ||
| Endometrial carcinoma: two diseases? | Q68985424 | ||
| Pitfalls in the diagnosis of endometrial neoplasia | Q70364538 | ||
| Predicting the outcome of endometrial hyperplasia by quantitative analysis of nuclear features using a linear discriminant function | Q71827517 | ||
| Endometrial polyps with predominant stromal component are characterized by a t(6;14)(p21;q24) translocation | Q72368572 | ||
| Association of soy and fiber consumption with the risk of endometrial cancer | Q73623996 | ||
| Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecological malignancies | Q73722520 | ||
| Gatekeeper for endometrium: the PTEN tumor suppressor gene | Q73862115 | ||
| Reproducibility of the diagnosis of endometrial hyperplasia, atypical hyperplasia, and well-differentiated carcinoma | Q77101600 | ||
| A multicentric European study testing the reproducibility of the WHO classification of endometrial hyperplasia with a proposal of a simplified working classification for biopsy and curettage specimens | Q78229371 | ||
| Genesis of endometrial carcinoma; study of prior biopsies | Q80623743 | ||
| Genesis of endometrial carcinoma; carcinoma in situ | Q80623749 | ||
| Nuclear morphometry in the determination of the prognosis of marked atypical endometrial hyperplasia | Q93633000 | ||
| A polymerase chain reaction assay for non-random X chromosome inactivation identifies monoclonal endometrial cancers and precancers | Q24684145 | ||
| Histopathology of genetically defined endometrial precancers | Q28139645 | ||
| Endometrial intraepithelial neoplasia (EIN): will it bring order to chaos? The Endometrial Collaborative Group | Q28145283 | ||
| Endometrial precancer diagnosis by histopathology, clonal analysis, and computerized morphometry | Q28145738 | ||
| Altered PTEN expression as a diagnostic marker for the earliest endometrial precancers | Q28145813 | ||
| The behavior of endometrial hyperplasia. A long-term study of "untreated" hyperplasia in 170 patients | Q28235260 | ||
| Early mutational activation of the c-Ki-ras oncogene in endometrial carcinoma | Q28251010 | ||
| Analysis of clonality in archival tissues by polymerase chain reaction amplification of PGK-1 | Q28251746 | ||
| Mutation of the Ki-ras protooncogene in human endometrial hyperplasia and carcinoma | Q28267816 | ||
| Mutation of the PTEN tumor suppressor gene in endometrial hyperplasias | Q28274383 | ||
| Uteri of women with endometrial carcinoma contain a histopathological spectrum of monoclonal putative precancers, some with microsatellite instability | Q28277479 | ||
| PTEN mutations and microsatellite instability in complex atypical hyperplasia, a precursor lesion to uterine endometrioid carcinoma | Q28279165 | ||
| Analysis of clonality by polymerase chain reaction for phosphoglycerate kinase-1. Heteroduplex generator | Q28284662 | ||
| MLH1 promoter hypermethylation is associated with the microsatellite instability phenotype in sporadic endometrial carcinomas | Q28288475 | ||
| Allelotype mapping of unstable microsatellites establishes direct lineage continuity between endometrial precancers and cancer | Q28290506 | ||
| X chromosome inactivation in the normal female genital tract: implications for identification of neoplasia | Q28291098 | ||
| Detection of clonality and genetic alterations in endometrial pipelle biopsy and its surgical specimen counterpart | Q28302287 | ||
| Endometrial histopathology in 700 patients treated with tamoxifen for breast cancer | Q33991524 | ||
| Risk and prognosis of endometrial cancer after tamoxifen for breast cancer. Comprehensive Cancer Centres' ALERT Group. Assessment of Liver and Endometrial cancer Risk following Tamoxifen | Q34063533 | ||
| Mutation and cancer: a model for human carcinogenesis | Q34273649 | ||
| Two pathogenetic types of endometrial carcinoma | Q34713298 | ||
| Characterization of estrogenicity of phytoestrogens in an endometrial-derived experimental model | Q34938840 | ||
| Computerised morphometrical analysis in endometrial hyperplasia for the prediction of cancer development. A long-term retrospective study from northern Norway | Q35396993 | ||
| Immunohistochemical evidence of loss of PTEN expression in primary ductal adenocarcinomas of the breast | Q35788322 | ||
| Use of computerized morphometric analyses of endometrial hyperplasias in the prediction of coexistent cancer | Q36849951 | ||
| The epidemiology of endometrial cancer | Q37712242 | ||
| Mutation and cancer: the antecedents to our studies of adaptive mutation. | Q41749616 | ||
| Pten, a protean tumor suppressor | Q42125233 | ||
| Changes in endometrial PTEN expression throughout the human menstrual cycle | Q42489118 | ||
| Clonal 6p21 rearrangement is restricted to the mesenchymal component of an endometrial polyp | Q43923429 | ||
| Assessment of the risk on endometrial cancer in hyperplasia, by means of morphological and morphometrical features | Q43980911 | ||
| Molecular identification of latent precancers in histologically normal endometrium. | Q53398436 | ||
| PTEN/MMAC1 mutations in endometrial cancers. | Q53439663 | ||
| The PTEN, BAX, and IGFIIR genes are mutated in endometrial atypical hyperplasia. | Q55341284 | ||
| High incidence of breast and endometrial neoplasia resembling human Cowden syndrome in pten+/- mice | Q57272679 | ||
| Regulation of human estrogen receptor by phytoestrogens in yeast and human cells | Q60147553 | ||
| The precursors of endometrial carcinoma | Q66970019 | ||
| K-ras activation in premalignant and malignant epithelial lesions of the human uterus | Q68003898 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 326-331 | |
| P577 | publication date | 2002-05-01 | |
| P1433 | published in | Journal of Clinical Pathology | Q6294965 |
| P1476 | title | Diagnosis of premalignant endometrial disease | |
| P478 | volume | 55 |
| Q37460521 | Altered PTEN expression; a diagnostic marker for differentiating normal, hyperplastic and neoplastic endometrium |
| Q37305411 | Angiogenesis in pre-malignant conditions |
| Q39960771 | Automatic measurement of volume percentage stroma in endometrial images using texture segmentation |
| Q47261979 | BCL-2 and PAX2 Expressions in EIN which Had Been Previously Diagnosed as Non-Atypical Hyperplasia |
| Q40079686 | Bariatric surgery and endometrial pathology in asymptomatic morbidly obese women: a prospective, pilot study |
| Q85212512 | Comparison of endometrial intraepithelial neoplasia with WHO endometrial hyperplasia classification system. A comparative study of 150 cases |
| Q86111497 | DNA methylation as a biomarker for the detection of hidden carcinoma in endometrial atypical hyperplasia |
| Q36493879 | Does the radiofrequency impedance-controlled endometrial ablation have any morphologic effects on uterine leiomyomata? Report of 3 cases |
| Q43010392 | EIN and WHO94. |
| Q95806002 | Endometrial Glandular Dysplasia (EmGD): morphologically and biologically distinctive putative precursor lesions of Type II endometrial cancers |
| Q36530267 | Endometrial biopsy: a karyometric and stereological study |
| Q36608842 | Endometrial carcinoma risk among women diagnosed with endometrial hyperplasia: the 34-year experience in a large health plan |
| Q36952350 | Endometrial intraepithelial neoplasia is associated with polyps and frequently has metaplastic change. |
| Q36174374 | Evaluation of PTEN immunoexpression in oral submucous fibrosis: role in pathogenesis and malignant transformation |
| Q35569362 | Hertig and Beyond: A Systematic and Practical Approach to the Endometrial Biopsy |
| Q48035535 | Involution of PTEN-null endometrial glands with progestin therapy |
| Q91296617 | Loss of heterozygosity and immunoexpression of PTEN in oral epithelial dysplasia and squamous cell carcinoma |
| Q35770233 | My approach to the interpretation of endometrial biopsies and curettings |
| Q34467239 | Nrf2 expression in endometrial serous carcinomas and its precancers. |
| Q51922221 | Objective risk definition for endometrial lesion spectrum: a diagnostic algorithm. |
| Q85016483 | PTEN-loss and nuclear atypia of EIN in endometrial biopsies can predict the existence of a concurrent endometrial carcinoma |
| Q38844574 | Paired boxed gene 1 expression: A single potential biomarker for differentiating endometrial lesions associated with favorable outcomes in patients with endometrial carcinoma |
| Q53174208 | Personal history of breast cancer as a significant risk factor for endometrial serous carcinoma in women aged 55 years old or younger. |
| Q24647890 | Prediction of endometrial carcinoma by subjective endometrial intraepithelial neoplasia diagnosis |
| Q82485208 | Predictors of resolution of complex atypical hyperplasia or grade 1 endometrial adenocarcinoma in premenopausal women treated with progestin therapy |
| Q39556716 | Quantification of differences in the effective atomic numbers of healthy and cancerous tissues: a discussion in the context of diagnostics and dosimetry |
| Q53095157 | Reproducibility of endometrial intraepithelial neoplasia diagnosis is good, but influenced by the diagnostic style of pathologists. |
| Q64939276 | Role of Morphometry and Matrix Metalloproteinase-9 Expression in Differentiating between Atypical Endometrial Hyperplasia and Low Grade Endometrial Adenocarcinoma |
| Q81757947 | Significance of benign endometrial cells in papanicolaou tests from women aged >or=40 years |
| Q37078918 | Squamous morules are functionally inert elements of premalignant endometrial neoplasia |
| Q47333181 | The coexistence of ERBB2, INT2, and CMYC oncogene amplifications and PTEN gene mutations in endometrial carcinoma. |
| Q37251777 | The endometrial hyperplasias revisited |
| Q24646398 | The molecular genetics and morphometry-based endometrial intraepithelial neoplasia classification system predicts disease progression in endometrial hyperplasia more accurately than the 1994 World Health Organization classification system |
Search more.